Get Quote

Emergent BioSolutions, Inc. (NYSE:EBS)

CAPS Game Rating: 5 out of 5

A biopharmaceutical company focused on the development, manufacture and commercialization of immunobiotics. The Company operates in two business segments: biodefense and commercial.

Recs

0
Member Avatar williamscaps (< 20) Submitted: 27/09/2010 12:55:42 : Underperform Start Price: $18.80 EBS Score: +64.36

18.78

Report this Post Reply

For details about CAPS-UK, and the conditions you agree to be bound by, please see our Terms and Conditions.